Vistance Networks (VISN) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
21 Dec, 2025Executive summary
Q4 2024 core net sales reached $1.17 billion, up 27% year-over-year, with core Adjusted EBITDA of $240 million, up 69%, and margin at 20.6%.
Full year 2024 core net sales were $4.21 billion, down 8% year-over-year, with core Adjusted EBITDA of $756 million, flat year-over-year; project delays and inventory normalization impacted results.
Completed the sale of OWN and DAS businesses in January 2025, using proceeds to pay down $2 billion in debt and strengthen the balance sheet.
Datacenter business showed strong growth, with expectations for double-digit expansion over the next five years, driven by cloud and hyperscale demand.
Q4 GAAP loss from continuing operations was $65.2 million, a significant improvement from $414.0 million loss in Q4 2023.
Financial highlights
Q4 2024 core net sales: $1.17 billion (+27% YoY); core Adjusted EBITDA: $240 million (+69% YoY); margin: 20.6%.
Full year 2024 core net sales: $4.21 billion (-8% YoY); core Adjusted EBITDA: $756 million (flat YoY); margin: 18.0%.
Q4 adjusted EPS improved to $0.18 from $(0.34) YoY; full year adjusted EPS at $(0.03) vs $(0.37) prior year.
Q4 free cash flow was $270.5 million; full year free cash flow was $247.8 million.
Ended 2024 with $1.1 billion in total liquidity.
Outlook and guidance
2025 core Adjusted EBITDA guidance is $1.00 to $1.05 billion, with a stronger second half expected.
Anticipating approximately 20% revenue growth year-over-year in 2025.
2025 adjusted free cash flow outlook: $25 million–$30 million.
First quarter 2025 expected to be seasonally lower in revenue and EBITDA.
Expecting break-even cash flow for 2025, with over $200 million in capex and working capital investments.
Latest events from Vistance Networks
- Director elections, executive pay, auditor ratification, and incentive plan shares up for vote.VISN
Proxy filing23 Mar 2026 - Proxy outlines director elections, executive pay, auditor ratification, and major ESG progress.VISN
Proxy filing23 Mar 2026 - Core adjusted EBITDA up 176% in 2025; $10/share special distribution planned.VISN
Q4 202526 Feb 2026 - Adjusted EBITDA up nearly 20% as CCS growth offsets declines; $2.1B OWN/DAS sale to aid liquidity.VISN
Q2 20242 Feb 2026 - Core adjusted EBITDA rose 25% on strong CCS gains; OWN and DAS divestiture set for Q1 2025.VISN
Q3 202416 Jan 2026 - Core adjusted EBITDA up 159% on 23.5% sales growth; 2025 guidance reaffirmed.VISN
Q1 202524 Dec 2025 - Definitive agreement to sell CCS segment to Amphenol, pending shareholder approval and regulatory review.VISN
Proxy Filing2 Dec 2025 - CCS business sale unlocks equity, enables debt repayment, and sets up a major shareholder dividend.VISN
Proxy Filing1 Dec 2025 - $10.5B sale of CCS segment to Amphenol, pending approvals and board support.VISN
Proxy Filing1 Dec 2025